BILATERAL CHRONIC SUBDURAL HEMATOMA – CLINICAL PRESENTATION, RISK FACTORS, MANAGEMENT AND OUTCOME: A SINGLE CENTRE EXPERIENCE FROM NORTH-EASTERN INDIA

Abstract

Study design: Background: Retrospective hospital-based study. Annual incidence of bilateral Chronic Subdural Hematoma (CSDH) is increasing due to an increase in the aging population, associated medical comorbidities such as hemodialysis, anticoagulant and/or antiplatelet therapy. 1. To study the clinical spectrum of Bilateral Chronic Subdural Hematoma Objectives: patients. 2. To study the treatment modalities used and outcome of the patients. A retrospective hospital-based study was carried Method: out on 50 conrmed patients of bilateral CSDH. Information of patients such as socio-demographic prole, clinical presentation, and laboratory investigations, along with treatment and outcome were recorded and analyzed. Among 50 patients, male and female were 80% and 20% res Results: pectively. The mean age of patients was 62.08 years. A history of head injury was reported by 40% of patients. The mean Glasgow coma scale (GCS) was 12.24. Common presenting symptoms were headache (76%), hemiparesis (40%), aphasia (28%), complete loss of consciousness (20%). Clinical improvement was observed in 80% while 10% had no change, 04% showed clinical deterioration and 06% of patients died during treatment. Bilateral CSDH is common Conclusion: in the elderly and prognosis is poor with increasing age. Bilateral hematoma has a higher risk of acute deterioration of clinical symptoms because of downward herniation, resulting in a poor clinical outcome. Timely interventions can improve the outcome in bilateral CSDH patients.